Cargando…

Fe(3)O(4)-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis

Thrombotic disease is a great threat to human health, and early detection is particularly important. Magnetic resonance (MR) molecular imaging provides noninvasive imaging with the potential for early disease diagnosis. In this study, we developed Fe(3)O(4)-based poly(lactic-co-glycolic acid) (PLGA)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jia, Xu, Jie, Zhou, Jun, Zhang, Yu, Guo, Dajing, Wang, Zhigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310639/ https://www.ncbi.nlm.nih.gov/pubmed/28223802 http://dx.doi.org/10.2147/IJN.S123228

Ejemplares similares

An ultra-sensitive T(2)-weighted MR contrast agent based on Gd(3+) ion chelated Fe(3)O(4) nanoparticles
por: Chen, Jing, et al.
Publicado: (2020)

Synthesis of Fe(3)O(4)-Gold hybrid nanoparticles coated by bovine serum albumin as a contrast agent in MR imaging
por: Danafar, Hossein, et al.
Publicado: (2023)

Preparation and characterization of gadolinium-loaded PLGA particles surface modified with RGDS for the detection of thrombus
por: Zhang, Yu, et al.
Publicado: (2013)

Co-encapsulation of magnetic Fe(3)O(4) nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery
por: Jia, Yanhui, et al.
Publicado: (2012)

Aluminium hydroxide stabilised MnFe(2)O(4) and Fe(3)O(4) nanoparticles as dual-modality contrasts agent for MRI and PET imaging
por: Cui, Xianjin, et al.
Publicado: (2014)

Novel MR imaging contrast agents for cancer detection
por: Shahbazi-Gahrouei, Daryoush
Publicado: (2009)

Near-infrared induced phase-shifted ICG/Fe(3)O(4) loaded PLGA nanoparticles for photothermal tumor ablation
por: Niu, Chengcheng, et al.
Publicado: (2017)

PLGA+Fe(3)O(4)+PFP Nanoparticles Drug-Delivery Demonstrates Potential Anti-Tumor Effects on Tumor Cells
por: Yang, Dayan, et al.
Publicado: (2022)

Synthesis and Application of Fe(3)O(4)@Au Composite Nanoparticles as Magnetic Resonance/Computed Tomography Dual-Modality Contrast Agent
por: Keshtkar, Mohammad, et al.
Publicado: (2020)

PMMA-Fe(3)O(4) for internal mechanical support and magnetic thermal ablation of bone tumors
por: Yu, Kexiao, et al.
Publicado: (2019)

Injectable PLGA/Fe(3)O(4) implants carrying cisplatin for synergistic magnetic hyperthermal ablation of rabbit VX2 tumor
por: Yang, Yang, et al.
Publicado: (2017)

Surface Characteristics Affect the Properties of PLGA Nanoparticles as Photothermal Agents
por: Kovalenko, Vera L., et al.
Publicado: (2023)

Controlled intracellular self-assembly of gadolinium nanoparticles as smart molecular MR contrast agents
por: Cao, Chun-Yan, et al.
Publicado: (2013)

Magnetic Iron Oxide Nanoparticles as T(2) MR Imaging Contrast Agent for Detection of Breast Cancer (MCF-7) Cell
por: Moradi Khaniabadi, Pegah, et al.
Publicado: (2017)

Polydopamine-modified dual-ligand nanoparticles as highly effective and targeted magnetic resonance/photoacoustic dual-modality thrombus imaging agents
por: Zhang, Yu, et al.
Publicado: (2019)

Construction of Multifunctional Fe(3)O(4)-MTX@HBc Nanoparticles for MR Imaging and Photothermal Therapy/Chemotherapy
por: Zhang, Qiang, et al.
Publicado: (2018)

Facile Preparation of Gold-Decorated Fe(3)O(4) Nanoparticles for CT and MR Dual-Modal Imaging
por: Cai, Jing, et al.
Publicado: (2018)

EGFR-specific single-chain variable fragment antibody-conjugated Fe(3)O(4)/Au nanoparticles as an active MRI contrast agent for NSCLC
por: Lu, Yuan, et al.
Publicado: (2021)

Preparation of PLGA Nanoparticles by Milling Spongelike PLGA Microspheres
por: Lee, Jimin, et al.
Publicado: (2022)

Fe(3)O(4) Nanoparticles Loaded on Lignin Nanoparticles Applied as a Peroxidase Mimic for the Sensitively Colorimetric Detection of H(2)O(2)
por: Zhang, Qingtong, et al.
Publicado: (2019)

Imaging Characteristics of USPIO Nanoparticles (<5 nm) as MR Contrast Agent In Vitro and in the Liver of Rats
por: Ma, Xiaohong, et al.
Publicado: (2019)

Thrombin@Fe(3)O(4) nanoparticles for use as a hemostatic agent in internal bleeding
por: Shabanova, Emiliya M., et al.
Publicado: (2018)

New Span-PEG-composited Fe(3)O(4)-CNT as a multifunctional ultrasound contrast agent for inflammation and thrombotic niduses
por: Zhang, Jie, et al.
Publicado: (2020)

Profound Interfacial Effects in CoFe(2)O(4)/Fe(3)O(4) and Fe(3)O(4)/CoFe(2)O(4) Core/Shell Nanoparticles
por: Polishchuk, Dmytro, et al.
Publicado: (2018)

Laser Ablation of NiFe(2)O(4) and CoFe(2)O(4) Nanoparticles
por: Sachse, Erik, et al.
Publicado: (2022)

Superparamagnetic Fe(3)O(4)@CA Nanoparticles and Their Potential as Draw Solution Agents in Forward Osmosis
por: Petrinic, Irena, et al.
Publicado: (2021)

Anti-CD206 antibody-conjugated Fe(3)O(4)-based PLGA nanoparticles selectively promote tumor-associated macrophages to polarize to the pro-inflammatory subtype
por: Zhou, Yun, et al.
Publicado: (2020)

Tumor-targeted Gd-doped mesoporous Fe(3)O(4) nanoparticles for T(1)/T(2) MR imaging guided synergistic cancer therapy
por: Zheng, Shaohui, et al.
Publicado: (2021)

Targeted T(1) Magnetic Resonance Imaging Contrast Enhancement with Extraordinarily Small CoFe(2)O(4) Nanoparticles
por: Piché, Dominique, et al.
Publicado: (2019)

Concurrent Dual-Contrast Enhancement Using Fe(3)O(4) Nanoparticles to Achieve a CEST Signal Controllability
por: Hu, Feixiang, et al.
Publicado: (2023)

Efficacy of surface-functionalized Mg(1−x)Co(x)Fe(2)O(4) (0 ≤ x ≤ 1; Δx = 0.1) for hyperthermia and in vivo MR imaging as a contrast agent
por: Islam, M. Aminul, et al.
Publicado: (2022)

Magnetic Fe(3)O(4) nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cells
por: Jing, Hongmei, et al.
Publicado: (2010)

Shape-controlled synthesis of magnetic Fe(3)O(4) nanoparticles with different iron precursors and capping agents
por: Fatima, Hira, et al.
Publicado: (2018)

Large exchange bias in Cr substituted Fe(3)O(4) nanoparticles with FeO subdomains
por: Bulbucan, Claudiu, et al.
Publicado: (2021)

Study of Phase Transformations and Hyperfine Interactions in Fe(3)O(4) and Fe(3)O(4)@Au Nanoparticles
por: Rusakov, Vyacheslav S., et al.
Publicado: (2022)

Caveolae-mediated mesenchymal stem cell labelling by PSS-coated PLGA PFOB nano-contrast agent for MRI
por: Quang, Hieu Vu, et al.
Publicado: (2018)

Size-regulated group separation of CoFe(2)O(4) nanoparticles using centrifuge and their magnetic resonance contrast properties
por: Kang, Jongeun, et al.
Publicado: (2013)

Manganese Ferrite Nanoparticles (MnFe(2)O(4)): Size Dependence for Hyperthermia and Negative/Positive Contrast Enhancement in MRI
por: Islam, Khairul, et al.
Publicado: (2020)

Superparamagnetic iron oxide-C595: Potential MR imaging contrast agents for ovarian cancer detection
por: Shahbazi-Gahrouei, Daryoush, et al.
Publicado: (2013)

Correction: Efficacy of surface-functionalized Mg(1−x)Co(x)Fe(2)O(4) (0 ≤ x ≤ 1; Δx = 0.1) for hyperthermia and in vivo MR imaging as a contrast agent
por: Islam, M. Aminul, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_20hbpjjt2rfcq3jioggtvp1ooj